Skip to content
PLYXPolaryx Therapeutics, Inc.

PLYX holders

Who holds Polaryx Therapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
13
Shares held
2.1M
Value held
$4.2M
Opened
2
Closed
2

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Vanguard Capital Management LLC1.7M−0.1%$3.4M0.1%Nov 13, 2026
Geode Capital Management, LLC138.8K−18.9%$287.4K0%Nov 6, 2026
Vanguard Fiduciary Trust Co80.3K−23.6%$166.3K0%Nov 13, 2026
State Street Corp68K+17.0%$140.8K0%Nov 12, 2026
BlackRock, Inc.41K±0%$84.9K0%Nov 13, 2026
Northern Trust Corp28K±0%$57.9K0%Nov 16, 2026
Cerity Partners LLC10.4KNew$21.6K0%Nov 13, 2026
Allworth Financial LP7.7K±0%$16K0.1%Nov 17, 2026
Vanguard Global Advisers, LLC6.3K±0%$13.1K0%Nov 13, 2026
UBS Group AG4.4K+239.4%$9K0%Nov 10, 2026
Tower Research Capital LLC (TRC)1.9K−38.2%$3.8K0%Nov 16, 2026
HRT Financial LP33.1K−59.7%$680.1%Nov 13, 2026
Barclays PLC9New$190%Nov 6, 2026